Medical Journals

Directed Differentiation of Human Embryonic Stem Cells into Functional Dendritic Cells Through the Myeloid Pathway.

Authors:
  • Slukvin Igor I
  • Vodyanik Maxim A
  • Thomson James A
  • Gumenyuk Maryna E
  • Choi Kyung-Dal

From: Department of Pathology and Laboratory Medicine, Wisconsin National Primate research Center, University of Wisconsin, Madison, WI 53706, USA. islukvin@wisc.edu

Journal of immunology (Baltimore, Md. : 1950)

  • Publish Date: Mar 2006
  • ISSN: 0022-1767
  • Volume: 176
  • Issue: 5
  • Pages: 2924-32
  • Medium: Print
  • Language: English
  • Citation (JAMA): Slukvin Igor I, Vodyanik Maxim A, Thomson James A, et al. Directed Differentiation of Human Embryonic Stem Cells into Functional Dendritic Cells Through the Myeloid Pathway.. J. Immunol. Mar 2006;176:2924-32

Abstract

We have established a system for directed differentiation of human embryonic stem (hES) cells into myeloid dendritic cells (DCs). As a first step, we induced hemopoietic differentiation by coculture of hES cells with OP9 stromal cells, and then, expanded myeloid cells with GM-CSF using a feeder-free culture system. Myeloid cells had a CD4+CD11b+CD11c+CD16+CD123(low)HLA-DR- phenotype, expressed myeloperoxidase, and included a population of M-CSFR+ monocyte-lineage committed cells. Further culture of myeloid cells in serum-free medium with GM-CSF and IL-4 generated cells that had typical dendritic morphology; expressed high levels of MHC class I and II molecules, CD1a, CD11c, CD80, CD86, DC-SIGN, and CD40; and were capable of Ag processing, triggering naive T cells in MLR, and presenting Ags to specific T cell clones through the MHC class I pathway. Incubation of DCs with A23187 calcium ionophore for 48 h induced an expression of mature DC markers CD83 and fascin. The combination of GM-CSF with IL-4 provided the best conditions for DC differentiation. DCs obtained with GM-CSF and TNF-alpha coexpressed a high level of CD14, and had low stimulatory capacity in MLR. These data clearly demonstrate that hES cells can be used as a novel and unique source of hemopoietic and DC precursors as well as DCs at different stages of maturation to address essential questions of DC development and biology. In addition, because ES cells can be expanded without limit, they can be seen as a potential scalable source of cells for DC vaccines or DC-mediated induction of immune tolerance.

Mesh Headings (Keywords): Animals, Cell Differentiation, Cell Line, Cells, Cultured, Coculture Techniques, Dendritic Cells, Embryo, Mammalian, Granulocyte-Macrophage Colony-Stimulating Factor, Humans, Mice, Myeloid Cells, Signal Transduction, Stem Cells, T-Lymphocytes


Check for Full Text / PubMed Unique Identifier (PMID): 16493050


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.